Epizyme Inc (EPZM)
Epizyme Inc (EPZM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | |
| Cash Flows From Operating Activities | |
| Net Income | -20,957 |
| Depreciation Amortization | 479 |
| Accounts receivable | -1,872 |
| Accounts payable and accrued liabilities | 1,284 |
| Other Working Capital | 30,149 |
| Other Operating Activity | 917 |
| Operating Cash Flow | $10,000 |
| Cash Flows From Investing Activities | |
| PPE Investments | -918 |
| Investing Cash Flow | $-918 |
| Cash Flows From Financing Activities | |
| Common Stock Issued | 104 |
| Other Financing Activity | 18,979 |
| Financing Cash Flow | $19,083 |
| Beginning Cash Position | 5,176 |
| End Cash Position | 33,341 |
| Net Cash Flow | $28,165 |
| Free Cash Flow | |
| Operating Cash Flow | 10,000 |
| Capital Expenditure | -918 |
| Free Cash Flow | 9,082 |